CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BIMI Holdings Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BIMI Holdings Inc
725 5Th Avenue, 15Th Floor, 15-01
Phone: (212) 542-0028p:212 542-0028 NEW YORK, NY  404100  United States Ticker: BIMIBIMI

Business Summary
BIMI Holdings Inc., formerly BIMI International Medical Inc., is a healthcare products and services provider. The Company offers a range of healthcare products and related services in the United States and Asia. The Company operates in four segments: wholesale pharmaceuticals, wholesale medical devices, medical services and retail pharmacy. The wholesale pharmaceuticals segment includes supplying prescription and over the counter (OTC) medicines, traditional Chinese medicines (TCM), healthcare supplies and sundry items to clinics, third party pharmacies, hospitals and other drug wholesalers. The wholesale medical devices segment distributes medical devices, including medical consumables, to private clinics, hospitals, third party pharmacies and other medical device dealers. The retail pharmacy segment sells prescription and OTC medicines, TCM, healthcare supplies and sundry items to retail customers through its directly owned pharmacies and authorized retail stores.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202312/31/2022YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, President FnuOudom 68 5/12/2022 5/9/2022
Chief Executive Officer, Director TieweiSong 51 5/9/2022 5/18/2018
Interim Chief Financial Officer BaiqunZhong 61 9/27/2021 5/21/2021
4 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Chongqing Guanzhou Technology Co., Ltd. China
Phenix Bio Inc. 5412 Lakeview Ave Yorba Linda CA United States

Business Names
Business Name
Beijing Xinrongxin
Bimai Hospital Management
Bimai Pharmaceutical
40 additional Business Names available in full report.

General Information
Number of Employees: 296 (As of 12/31/2022)
Outstanding Shares: 13,589,569 (As of 1/2/2024)
Shareholders: 960
Stock Exchange: NASD
Federal Tax Id: 020563302
Fax Number: (302) 636-5454


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 19, 2024